JESUS TORRES: Open Payments
NPI 1275819328 · SPRING BRANCH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 23 payments from 9 companies in 2025. Trend: 2023 $1,033 · 2024 $1,069 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $116 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Novo Nordisk Inc | 4 | $71 |
| Astellas Pharma US Inc | 2 | $50 |
| Abbott Laboratories | 2 | $41 |
| ABBVIE INC. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Exact Sciences Corporation | 1 | $18 |
| Amgen Inc. | 1 | $14 |
Products named: MOUNJARO, Ozempic, Veozah, BREZTRI, ELIQUIS, FREESTYLE LIBRE 3, Cologuard Collection Kit, Rybelsus.
Industry payments across TX — which companies pay providers there.
